S6256
磺胺二甲基嘧啶
99.0-101.0% (on dried basis)
别名:
4,6-二甲基磺胺嘧啶, 4-氨基-N-（4,6-二甲基-2-嘧啶基）苯磺酰胺, 磺胺二甲嘧啶
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C12H14N4O2S
化学文摘社编号:
分子量:
278.33
UNSPSC Code:
51284910
NACRES:
NA.85
PubChem Substance ID:
EC Number:
200-346-4
Beilstein/REAXYS Number:
261304
MDL number:
Quality Level
assay
99.0-101.0% (on dried basis)
form
powder or crystals
storage condition
(Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.)
color
white to off-white
antibiotic activity spectrum
Gram-negative bacteria, Gram-positive bacteria
mode of action
DNA synthesis | interferes, enzyme | inhibits
storage temp.
2-8°C
SMILES string
Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1
InChI
1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)
InChI key
ASWVTGNCAZCNNR-UHFFFAOYSA-N
General description
化学结构式：磺酰胺
Application
磺胺二甲嘧啶是一种抗生素，用于治疗支气管炎、前列腺炎和尿路感染。用于处置和消除动力学研究。其用于开发液体（如牛奶、蜂蜜和猪尿）中的定量检测技术。
Biochem/physiol Actions
一种抗微生物的硫磺药物。诱导 CYP3A4 表达并被 N-乙酰转移酶乙酰化。表现出性别依赖性药代动力学，由男性特有的 CYP2C11 亚型代谢。
磺胺二甲嘧啶是一种抗微生物性硫药，通过抑制二氢喋呤合成酶而阻断二氢叶酸的合成。磺胺二甲嘧啶是细菌合成叶酸所需的对氨基苯甲酸 (PABA) 的竞争性抑制剂。诱导 CYP3A4 表达并被 N-乙酰转移酶乙酰化。它表现出性别依赖性药代动力学，由男性特有的 CYP2C11 亚型代谢。磺胺二甲嘧啶具有抑菌作用。
Packaging
25G,100G
Other Notes
将容器密闭保存在干燥和通风良好的地方。在干燥处保存。
Still not finding the right product?
Explore all of our products under 磺胺二甲基嘧啶
存储类别
11 - Combustible Solids
ppe
Eyeshields, Gloves, type N95 (US)
signalword
Warning
hcodes
Hazard Classifications
Skin Irrit. 2
flash_point_f
Not applicable
flash_point_c
Not applicable
A D Mitchell et al.
Drug metabolism and disposition: the biological fate of chemicals, 14(2), 161-165 (1986-03-01)
Swine weighing 60-70 kg were orally administered 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] at 12-hr intervals for 7 days (165 mg/dose; 0.126-5.04 mCi/mmol). The animals were sacrificed at 8 hr or 2, 5, or 10 days after the last dose was given and tissues
Tangbin Yang et al.
Hybridoma (2005), 29(5), 403-407 (2010-11-06)
A specific monoclonal antibody (MAb) against sulfamethazine was produced with hybridoma technology. This assay shows very high sensitivity with IC50 of 0.4 ng/mL and LOD of 0.05 ng/mL when it was run in 0.02 mol/L PBS (pH 7.5). This MAb has shown high
M Rérat et al.
Preventive veterinary medicine, 103(4), 265-273 (2011-09-29)
The present study was conducted to evaluate the efficacy of two prophylactic antibiotic treatments against bovine respiratory disease (BRD) in veal calves. In addition, the antibiotic susceptibilities of isolated Pasteurellaceae were tested. The calves were treated either on the day
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| S6256-100G | 04061838345547 |
| S6256-25G | 04061835522545 |